Market Tracker

11/27 1:05pm ET

Trovagene Inc (NASDAQ:TROV)

4.45
Data as of Nov 26
 -0.24 / -5.12%
Today’s Change
2.97
Today|||52-Week Range
7.10
-22.47%
Year-to-Date

Today’s Trading

Previous close4.69
Today’s open4.74
Day’s range4.38 - 4.74
Volume90,154
Average volume (3 months)138,892
Market cap$84.1M
Dividend yield--
Data as of 3:59pm ET, 11/26/2014

Growth & Valuation

Earnings growth (last year)+21.35%
Earnings growth (this year)-13.57%
Earnings growth (next 5 years)--
Revenue growth (last year)-42.44%
P/E ratioNM
Price/Sales375.92
Price/Book4.13

Competitors

 Today’s
change
Today’s
% change
GALTGalectin Therapeutic...+0.02+0.47%
CGIXCancer Genetics Inc+0.04+0.71%
PANGPanacea Global Inc0.000.00%
APPYVenaxis Inc-0.02-1.18%
Data as of 3:59pm ET, 11/26/2014

Financials

Next reporting dateMarch 16, 2015
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$259.2K
Annual profit (last year)-$11.8M
Net profit margin-4,555.88%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Antonius P. Schuh
Chief Financial Officer
Stephen L. Zaniboni
Corporate headquarters
San Diego, California

Forecasts